Healthcare - Biotechnology - NASDAQ - US
$ 7.74
-8.73 %
$ 475 M
Market Cap
-3.49
P/E
BALANCE SHEET
304 M
ASSETS
125 M
LIABILITIES
179 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Monte Rosa Therapeutics, Inc.
| Current Assets | 236 M |
| Cash & Short-Term Investments | 232 M |
| Receivables | 505 K |
| Other Current Assets | 3.29 M |
| Non-Current Assets | 67.5 M |
| Long-Term Investments | 0 |
| PP&E | 62.6 M |
| Other Non-Current Assets | 4.93 M |
| Current Liabilities | 46.6 M |
| Accounts Payable | 11.2 M |
| Short-Term Debt | 6.32 M |
| Other Current Liabilities | 29.1 M |
| Non-Current Liabilities | 77.9 M |
| Long-Term Debt | 42.9 M |
| Other Non-Current Liabilities | 35 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 128.1 | 54.9 | 346.1 | 41.7 | 6.0 |
| Short Term Investments | 104.3 | 207.9 | 0 | 0 | 0 |
| Receivables | 0.5 | 7.7 | 0 | 0 | 0 |
| Inventory | 0 | 1.0 | 0 | 0 | 0 |
| Other Current Assets | 3.3 | 5.4 | 5.2 | 1.8 | 3.8 |
| Total Current Assets | 236.2 | 275.9 | 348.7 | 43.6 | 9.8 |
| PP&E | 62.6 | 61.9 | 12.3 | 4.6 | 1.3 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 4.3 | 5.3 | 1.2 | 0 |
| Other Long Term Assets | 4.9 | 0.3 | 0 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 303.8 | 342.4 | 366.3 | 49.4 | 11.1 |
| LIABILITIES | |||||
| Accounts Payable | 11.2 | 7.9 | 6.6 | 7.1 | 3.2 |
| Short Term Debt | 6.3 | 6.3 | 0 | 0 | 0.8 |
| Other Current Liabilities | 11.4 | 11.5 | 10.1 | 22.2 | 0.3 |
| Total Current Liabilities | 46.6 | 25.6 | 16.6 | 29.3 | 4.3 |
| Long Term Debt | 42.9 | 43.9 | 0 | 67.8 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 2.7 | 1.5 | 2.2 | 0 | 0 |
| Total Liabilities | 124.5 | 71.0 | 18.8 | 98.1 | 23.2 |
| EQUITY | |||||
| Common Stock | 5 K | 5 K | 5 K | 1 K | 50 K |
| Retained Earnings | (365.9) | (230.5) | (122.0) | (48.1) | (12.2) |
| Other Accumulative Comprehensive Income/Loss | (2.7) | (1.8) | (2.0) | (1.1) | 69 K |
| Total Equity | 179.2 | 271.4 | 347.5 | (48.7) | (12.1) |
| Total Liabilities and Equity | 303.8 | 342.4 | 366.3 | 49.4 | 11.1 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 51.4 | 47.2 | 46.5 | 44.0 | 44.0 |